ISO 10993-6:2026

Overview

ISO 10993-6:2026 is a critical international standard developed by ISO that outlines methodologies for the biological evaluation of medical devices, focusing on tests for local effects after implantation. Part of the widely recognized ISO 10993 series, this standard provides requirements for implantation test methods used in preclinical assessment to evaluate local tissue responses triggered by medical devices or materials. This standard is essential for manufacturers, testing laboratories, and regulatory bodies in assessing the safety and compatibility of implantable devices and materials where direct or indirect contact with tissue occurs.

The standard is applicable to a broad range of medical device types including solid, non-solid (such as porous, gel, paste, powder, or particulate forms), absorbable, degradable, non-absorbable, and tissue-engineered medical products (TEMPs). It is designed to help ensure that evaluated devices do not cause unacceptable local tissue reactions at the intended site of implantation.

Key Topics

ISO 10993-6:2026 covers several important topics for the biological assessment of implantable medical devices:

• Preparation and selection of test samples: Guidance on preparing samples, including the use of finished-state devices, representative coupons, and sterility requirements.
• Control materials: Criteria for selecting comparative and reference control materials to ensure meaningful evaluation of local effects.
• Test animal models: Recommendations for appropriate animal species selection, number of animals, and care, in line with ISO 10993-2 and ethical considerations.
• Implantation sites: Criteria for site selection relevant to the device's intended clinical application.
• Evaluation periods: Recommendations for short-term and long-term implantation timeframes, linked to device material properties and degradation profiles.
• Study design documentation: Requirements for documentation regarding study methods, sample handling, animal welfare, and test outcomes.
• Assessment of tissue responses: Procedures for macroscopic and microscopic evaluation of the local tissue response, including gross pathology and histopathology.
• Reporting: Essential elements to be included in the test report, ensuring data transparency and reproducibility.
• Annexes: Normative and informative annexes provide detailed test methods for different tissue types (subcutaneous, muscle, bone, neural tissue), as well as scoring systems for biological effects.

Applications

ISO 10993-6:2026 is widely used in the medical device industry for:

• Preclinical safety evaluation: Ensuring that new medical devices, especially those that breach skin or mucosal barriers, do not elicit unacceptable local tissue responses.
• Regulatory compliance: Meeting international regulatory requirements for biological evaluation of medical devices under risk management processes.
• Device development and validation: Supporting the design and refinement of new devices and materials by providing structured protocols for assessing biocompatibility.
• Material selection: Assisting manufacturers in selecting appropriate materials for implantable devices based on observed tissue responses and comparative controls.
• Quality assurance: Standardizing implantation test methodologies and sample preparation to enhance the reliability of test results.

Related Standards

ISO 10993-6:2026 integrates seamlessly with other key standards in the ISO 10993 series and related documents, including:

• ISO 10993-1: General principles for the biological evaluation of medical devices.
• ISO 10993-2: Animal welfare requirements for biological testing.
• ISO 10993-4: Selection of tests for interactions with blood.
• ISO 10993-9: Identification and quantification of potential degradation products.
• ISO 10993-12: Preparation and reference materials for biological evaluation.
• ISO 10993-16: Toxicokinetic study design for degradation products and leachables.
• Additional sector-specific standards, such as ISO 11979-5 (intraocular lenses) and ISO 7405 (dental devices) for device-specific implantation testing.

ISO 10993-6:2026 remains a foundational document for the biological safety evaluation of implantable medical devices, supporting innovation, patient safety, and regulatory compliance.